Newsletter Archive

1. 12.12.25 -- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials 12/12/2025
   12/12/25 Clinical Leader Newsletter
2. 12.11.25 -- FDA First: Dompé Secures a Commissioner's National Priority Voucher 12/11/2025
   12/11/25 Clinical Leader Newsletter
3. 12.10.25 -- What The FDA Says About Investigator Responsibilities In DCTs 12/10/2025
   12/10/25 Clinical Leader Newsletter
4. 12.10.25 -- STREAM Edition: Rapid Design, Drug-Device Submissions, And The Global Burden Of Obesity 12/10/2025

   12/10/25 Clinical Leader Newsletter

5. 12.10.25 -- Global Trials And Oncology Insights 12/10/2025

   12/10/25 Clinical Leader Newsletter

6. 12.09.25 -- Can Digital Endpoints Really Accelerate Clinical Trials? 12/9/2025
   12/09/25 Clinical Leader Newsletter
7. 12.08.25 -- Sites Are 3X Likely To Die In The First Year Than New Businesses 12/8/2025
   12/08/25 Clinical Leader Newsletter
8. 12.05.25 -- GCP Oversight Simplified: A Quick Guide 12/5/2025
   12/05/25 Clinical Leader Newsletter
9. 12.04.25 -- Two Former FDA Chiefs, Two Very Different Warnings 12/4/2025
   12/04/25 Clinical Leader Newsletter
10. 12.04.25 -- Strategically Implementing Decentralized Clinical Trial Elements Drives ROI & Accelerates Timelines 12/4/2025

    12/04/25 Clinical Leader Newsletter